Insight Holdings Group, Llc Sells 142,311 Shares of Hinge Health (NYSE:HNGE) Stock

Hinge Health Inc. (NYSE:HNGE) major shareholder Insight Holdings Group, Llc sold 142,311 shares of the company’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $71.67, for a total transaction of $10,199,429.37. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Insight Holdings Group, Llc also recently made the following trade(s):

• On Wednesday, June 24th, Insight Holdings Group, Llc sold 390,917 shares of Hinge Health stock. The shares were sold at an average price of $71.15, for a total value of $27,813,744.55.
• On Tuesday, June 23rd, Insight Holdings Group, Llc sold 112,477 shares of Hinge Health stock. The shares were sold at an average price of $70.21, for a total value of $7,897,010.17.
• On Monday, June 22nd, Insight Holdings Group, Llc sold 224,399 shares of Hinge Health stock. The stock was sold at an average price of $70.95, for a total value of $15,921,109.05.
• On Tuesday, June 16th, Insight Holdings Group, Llc sold 65,581 shares of Hinge Health stock. The stock was sold at an average price of $70.36, for a total value of $4,614,279.16.

Hinge Health Trading Down 0.0%

Hinge Health stock opened at $70.36 on Thursday. The company has a market capitalization of $5.44 billion and a PE ratio of -5.70. Hinge Health Inc. has a 12 month low of $30.08 and a 12 month high of $72.39. The stock has a 50-day moving average price of $55.45 and a two-hundred day moving average price of $47.16.

Hinge Health (NYSE:HNGE) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.33. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.The company had revenue of $182.31 million for the quarter. During the same quarter last year, the firm posted $1.30 earnings per share. The business’s revenue for the quarter was up 47.2% on a year-over-year basis. As a group, analysts predict that Hinge Health Inc. will post 1.33 earnings per share for the current fiscal year.

Institutional Trading of Hinge Health

Institutional investors have recently added to or reduced their stakes in the stock. Wells Fargo & Company MN raised its holdings in Hinge Health by 160.0% during the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock worth $25,000 after purchasing an additional 336 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in shares of Hinge Health in the 4th quarter worth approximately $26,000. CENTRAL TRUST Co bought a new stake in shares of Hinge Health in the 1st quarter valued at $37,000. First Horizon Corp boosted its stake in shares of Hinge Health by 163.9% in the 4th quarter. First Horizon Corp now owns 855 shares of the company’s stock valued at $40,000 after purchasing an additional 531 shares during the last quarter. Finally, High Point Wealth Management LLC acquired a new stake in shares of Hinge Health during the fourth quarter worth $46,000.

Key Hinge Health News

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Hinge Health raised its Q2 2026 revenue guidance to $200 million-$202 million, above the Street’s $195 million estimate, and lifted full-year 2026 revenue guidance to $818 million-$824 million versus consensus of $801.6 million, signaling stronger growth expectations.
• Positive Sentiment: The stock continues to benefit from strong prior operating results, including revenue growth of 47.2% in the most recent reported quarter and earnings that beat analyst estimates, which supports the bullish analyst backdrop.
• Neutral Sentiment: Several analysts remain constructive on Hinge Health, with recent price targets in the $79-$90 range and a consensus rating of “Moderate Buy,” suggesting Wall Street still sees upside from current levels.
• Negative Sentiment: Major shareholder Insight Holdings Group sold a large block of shares in multiple June transactions, including 390,917 shares on June 24, 224,399 shares on June 22, and 112,477 shares on June 23, which can weigh on sentiment even though the sales were made under a pre-arranged 10b5-1 plan.
• Negative Sentiment: President James Pursley also sold 33,000 shares on June 22, adding to the cluster of insider selling that may raise concern about valuation after the stock’s recent run-up.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Robert W. Baird upped their price target on shares of Hinge Health from $55.00 to $65.00 and gave the company a “neutral” rating in a research report on Wednesday, June 17th. Citizens Jmp lifted their price target on shares of Hinge Health from $65.00 to $80.00 and gave the stock a “market outperform” rating in a report on Wednesday, May 6th. Weiss Ratings raised shares of Hinge Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 6th. Canaccord Genuity Group increased their price objective on Hinge Health from $65.00 to $76.00 and gave the company a “buy” rating in a report on Monday, June 15th. Finally, Citigroup reaffirmed an “outperform” rating on shares of Hinge Health in a research report on Wednesday, May 6th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Hinge Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $75.80.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.